Vestibulopathy clinical trials

Explore recruiting vestibulopathy clinical trials.

Recruiting vestibulopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vestibulopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

L-Thyroxine for the treatment of acute unilateral vestibulopathy (AUVP): a monocentric, double-blind, placebo-controlled trial (T4U)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Vestibulopathy trials by city

Vestibulopathy in Toronto Vestibulopathy in Vancouver Vestibulopathy in Montreal Vestibulopathy in Calgary Vestibulopathy in Edmonton Vestibulopathy in Ottawa Vestibulopathy in Winnipeg Vestibulopathy in Quebec City Vestibulopathy in Hamilton Vestibulopathy in Kitchener Vestibulopathy in London Vestibulopathy in Halifax Vestibulopathy in New York Vestibulopathy in Los Angeles Vestibulopathy in Chicago Vestibulopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease